Skip to main content
NCBI home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1976 Apr;24(1):210–217.

Suppressed hetergeneous antinuclear antibody response in lymphomabearing NZB/NZW mice.

S E Walker, G G Bole Jr
PMCID: PMC1538513  PMID: 1084817

Abstract

A long-term study of cyclophophamide-induced suppression of auto-immune disease in NZB/NZW mice demonstrated the oncogenic potential of this alkylating agent. In seven of ten mice dying with lymphomas, retrospective examination of serial tests for heterogeneous ANA showed terminal decreases of titres or reversion of tests to negative. Suppressed titres were found in one of seven mice dying with other tumours and in four of twenty-nine mice succumbing to renal disease-vasculitis. Transplantation studies confirmed the association between growing lymphoma tissue and decreasing ANA titres. In the immunosuppressed host with connective tissue disease, the loss of certain auto-antibodies may signal development of a lymphoreticular neoplasm. Tumour-induced impairment of auto-immune responsiveness may reflect the loss of specific ANA that fulfil a protective role and inhibit neoplastic growth.

Full text

PDF
210

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anderson L. G., Talal N. The spectrum of benign to malignant lymphoproliferation in Sjögren's syndrome. Clin Exp Immunol. 1972 Feb;10(2):199–221. [PMC free article] [PubMed] [Google Scholar]
  2. Carpenter D. F., Steinberg A. D., Schur P. H., Talal N. The pathogenesis of autoimmunity in New Zealand mice. II. Acceleration of glomerulonephritis by polyinosinic-polycytidylic acid. Lab Invest. 1970 Dec;23(6):628–634. [PubMed] [Google Scholar]
  3. Casey T. P. Systemic lupus erythematosus in NZB x NZW hybrid mice treated with the corticosteroid drug betamethasone. J Lab Clin Med. 1968 Mar;71(3):390–399. [PubMed] [Google Scholar]
  4. Hahn B. H., Knotts L., Ng M., Hamilton T. R. Influence of cyclophosphamide and other immunosuppressive drugs on immune disorders and neoplasia in NZB/NZW mice. Arthritis Rheum. 1975 Mar-Apr;18(2):145–152. doi: 10.1002/art.1780180212. [DOI] [PubMed] [Google Scholar]
  5. Lambert P. H., Dixon F. J. Genesis of antinuclear antibody in NZB-W mice: role of genetic factors and of viral infections. Clin Exp Immunol. 1970 Jun;6(6):829–839. [PMC free article] [PubMed] [Google Scholar]
  6. Lambert P. H., Dixon F. J. Pathogenesis of the glomerulonephritis of NZB/W mice. J Exp Med. 1968 Mar 1;127(3):507–522. doi: 10.1084/jem.127.3.507. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Penn I., Starzl T. E. Immunosuppression and cancer. Transplant Proc. 1973 Mar;5(1):943–947. [PMC free article] [PubMed] [Google Scholar]
  8. Pincus T., Schur P. H., Rose J. A., Decker J. L., Talal N. Measurement of serum DNA-binding activity in systemic lupus erythematosus. N Engl J Med. 1969 Sep 25;281(13):701–705. doi: 10.1056/NEJM196909252811304. [DOI] [PubMed] [Google Scholar]
  9. Russell P. J., Hicks J. D. Cyclophosphamide treatment of renal disease in (NZB x NZW) F1 hybrid mice. Lancet. 1968 Mar 2;1(7540):440–441. doi: 10.1016/s0140-6736(68)92778-5. [DOI] [PubMed] [Google Scholar]
  10. Siegel B. V., Brown M., Morton J. I. Immunodepressive effect of Rauscher leukemia virus on antinuclear antibody formation in New Zealand black mice. J Natl Cancer Inst. 1972 Jan;48(1):159–163. [PubMed] [Google Scholar]
  11. Steinberg A. D., Pincus T., Talal N. DNA-binding assay for detection of anti-DNA antibodies in NZB-NZW F1 mice. J Immunol. 1969 Mar;102(3):788–790. [PubMed] [Google Scholar]
  12. Talal N., Sokoloff L., Barth W. F. Extrasalivary lymphoid abnormalities in Sjögren's syndrome (reticulum cell sarcoma, "pseudolymphoma," macroglobulinemia). Am J Med. 1967 Jul;43(1):50–65. doi: 10.1016/0002-9343(67)90148-9. [DOI] [PubMed] [Google Scholar]
  13. Walker S. E., Bole G. G., Jr Augmented incidence of neoplasia in NZB-NZW mice treated with long-term cyclophosphamide. J Lab Clin Med. 1973 Oct;82(4):619–633. [PubMed] [Google Scholar]
  14. Walker S. E., Bole G. G., Jr Influence of natural and synthetic estrogens on the course of autoimmune disease in the NZB-NZW mouse. Arthritis Rheum. 1973 Mar-Apr;16(2):231–239. doi: 10.1002/art.1780160215. [DOI] [PubMed] [Google Scholar]
  15. Walker S. E., Bole G. G., Jr Selective suppression of autoantibody responses in NZB/NZW mice treated with long-term cyclophosphamide. Arthritis Rheum. 1975 May-Jun;18(3):265–272. doi: 10.1002/art.1780180312. [DOI] [PubMed] [Google Scholar]
  16. Yumoto T., Dmochowski L. Light and electron microscope studies of organs and tissues of the New Zealand Black (NZB/BL) strain mice with lymphoid leukemia and autoimmune disease. Cancer Res. 1967 Nov;27(11):2083–2097. [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES